The 40-Gene Expression Profile (40-GEP) Test Identifies Cutaneous Squamous Cell Carcinoma (cSCC) Patients at High Risk of Metastasis Within Lower-Staged Tumors to Better Guide Treatment Decisions. J of Skin 2024, 8 (2), s385. https://doi.org/10.25251/skin.8.supp.385.